19-13317133-C-T

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001127222.2(CACNA1A):​c.1534G>A​(p.Glu512Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000249 in 1,606,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E512Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 missense

Scores

8
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 3.33

Publications

0 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17014974).
BP6
Variant 19-13317133-C-T is Benign according to our data. Variant chr19-13317133-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 934341.
BS2
High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.1534G>A p.Glu512Lys missense_variant Exon 11 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.1534G>A p.Glu512Lys missense_variant Exon 11 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.1540G>A p.Glu514Lys missense_variant Exon 11 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.1396G>A p.Glu466Lys missense_variant Exon 10 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.1540G>A p.Glu514Lys missense_variant Exon 11 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.1537G>A p.Glu513Lys missense_variant Exon 11 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.1537G>A non_coding_transcript_exon_variant Exon 11 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.1534G>A non_coding_transcript_exon_variant Exon 11 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152114
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000242
AC:
6
AN:
248034
AF XY:
0.0000297
show subpopulations
Gnomad AFR exome
AF:
0.000131
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000889
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.0000241
AC:
35
AN:
1454692
Hom.:
0
Cov.:
31
AF XY:
0.0000235
AC XY:
17
AN XY:
722138
show subpopulations
African (AFR)
AF:
0.0000600
AC:
2
AN:
33328
American (AMR)
AF:
0.0000449
AC:
2
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26034
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39512
South Asian (SAS)
AF:
0.0000930
AC:
8
AN:
86010
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53320
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5748
European-Non Finnish (NFE)
AF:
0.0000181
AC:
20
AN:
1106122
Other (OTH)
AF:
0.0000333
AC:
2
AN:
60058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152232
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41544
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000386
Hom.:
0
Bravo
AF:
0.0000718
ESP6500AA
AF:
0.000249
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 21, 2020
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Spinocerebellar ataxia type 6;C1720416:Episodic ataxia type 2;C1832884:Migraine, familial hemiplegic, 1;C4310716:Developmental and epileptic encephalopathy, 42 Uncertain:1
Dec 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Jun 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.051
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.031
.;.;T;.;.;.;.;.;.;T;.;.;.;T;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.062
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;D;D;D;.;D;D;D;D;D;D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.17
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.034
D
MutationAssessor
Benign
1.9
.;.;.;.;L;.;.;L;.;.;.;.;L;.;.
PhyloP100
3.3
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-3.0
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.46
Sift
Benign
0.31
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.59
T;T;.;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
0.36
MVP
0.88
MPC
1.6
ClinPred
0.25
T
GERP RS
3.8
Varity_R
0.32
gMVP
0.63
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375210532; hg19: chr19-13427947; COSMIC: COSV64200231; COSMIC: COSV64200231; API